Clinical Evaluation and Biomarker Profiling of Hsp90 Inhibitors
Akira Yuno(National Institutes of Health), Jane B. Trepel, Yusuke Tomita(Center for Cancer Research), Min-Jung Lee(Center for Cancer Research), David Rekhtman(Center for Cancer Research), Brittni N. Moore(National Institutes of Health), Sunmin Lee(National Institutes of Health)
Cited by 122
Related Papers
Targeting the dynamic HSP90 complex in cancer
|Nature reviews. Cancer|2010|1.5k
Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations
|Journal for ImmunoTherapy of Cancer|2018|312
Destabilization of Raf-1 by Geldanamycin Leads to Disruption of the Raf-1–MEK–Mitogen-Activated Protein Kinase Signalling Pathway
|Molecular and Cellular Biology|1996|275